Computer-aided detection software developed by R2 Technology can now be marketed as an integral part of the GE Senographe 2000D full-field digital mammography system, following FDA approval. This is the latest step in R2's pioneering efforts to make CAD
Computer-aided detection software developed by R2 Technology can now be marketed as an integral part of the GE Senographe 2000D full-field digital mammography system, following FDA approval. This is the latest step in R2's pioneering efforts to make CAD a routine part of medical practice. The FDA approved the company's ImageChecker, a stand-alone CAD workstation, in 1998 for use with film-based screening mammography. Three years later the FDA expanded approval to include its use with diagnostic mammograms. R2 has shipped more than 400 film and digital-based systems worldwide. More than three million women have had their mammograms interpreted with the aid of the ImageChecker CAD system. Nearly 300 Senographe 2000D systems have been installed in the U.S. All are upgradable to R2's CAD technology.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.